Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

Most Read

  1. Poxel closes enrolment in TIMES 2 trial of Imeglimin in Japan
  2. Cocrystal Pharma to study hepatitis C drug in Hong Kong
  3. Allergan assesses brazikumab in two clinical programmes for IBD
  4. Cardax doses first patient in CHASE trial for cardiovascular health drug
  5. Oxurion enrols first patient in Phase l trial of THR-687 for DME

Latest Content

Novartis reports new positive data from MONALEESA trials

Novartis has reported positive results from three pivotal Phase III MONALEESA trials evaluating kisqali (ribociclib) plus endocrine therapy in combination with endocrine therapy alone for the treatment of human epidermal growth factor receptor-2 negative (HR+/HER2-) advanced breast cancer in patients with difficult-to-treat visceral disease.

Latest News

Read our magazine

Pharma Technology Focus is the essential reading material for decision-makers in the pharmaceutical industry, bringing you the latest news and analysis in an exciting, interactive format.

Send me notifications of new editions:

Go Top